汉字News

← 汉字News
Chinese News for Learners
commerce
shāng yè
商业
·HSK 4

Merck (US pharmaceutical company)
Mòkè
默克
to announce
xuānbù
宣布
at / for (price)
yǐ
以
$6.7 billion
67 yì měiyuán
67亿美元
to acquire
shōugòu
收购
Terns Pharmaceuticals (biotech company)
Terns Pharmaceuticals
Terns Pharmaceuticals
。

Merck company
Mòkè gōngsī
默克公司
to announce
xuānbù
宣布
at / for (price)
yǐ
以
approximately
yuē
约
$6.7 billion
67 yì měiyuán
67亿美元
to acquire
shōugòu
收购
Terns Pharmaceuticals (biotech company)
Terns Pharmaceuticals
Terns Pharmaceuticals
,
to obtain / to acquire
huòqǔ
获取
its
qí
其
leukemia
báixuèbìng
白血病
drug candidate
hòuxuǎn yàowù
候选药物
TERN-701 (oral leukemia drug candidate)
TERN-701
TERN-701
。
this / the current
cǐ cì
此次
merger and acquisition
bìnggòu
并购
aimed at
zhǐzài
旨在
to strengthen / to bolster
qiánghuà
强化
Merck
Mòkè
默克
structural particle
de
的
cancer
áizhèng
癌症
R&D / research and development
yánfā
研发
pipeline (pharmaceutical)
guǎnxiàn
管线
,
to address / to cope with
yǐ yìngduì
以应对
Keytruda (cancer immunotherapy drug)
Keytruda
Keytruda
patent
zhuānlì
专利
expiry / to expire
dàoqī
到期
structural particle
de
的
pressure / challenge
yālì
压力
。

March 25, 2026 at 6:00 PM

the United States
Měiguó
美国
pharmaceutical
zhìyào
制药
giant / major player
jùtóu
巨头
Merck company
Mòkè gōngsī
默克公司
on (date marker)
yú
于
March 25th
sānyuè èrshíwǔ rì
三月二十五日
announced
xuānbù
宣布
,
will / is to
jiāng
将
at / for (price)
yǐ
以
approximately
yuē
约
$6.7 billion
67 yì měiyuán
67亿美元
to acquire
shōugòu
收购
Terns Pharmaceuticals (biotech company)
Terns Pharmaceuticals
Terns Pharmaceuticals
。
this / the current
cǐ cì
此次
acquisition
shōugòu
收购
at
yǐ
以
per share
měi gǔ
每股
$53 per share
53 měiyuán
53美元
structural particle
de
的
price
jiàgé
价格
to proceed / to be conducted
jìnxíng
进行
,
compared to
jiào
较
recent / near-term
jìnqī
近期
share price
gǔjià
股价
at a premium
yìjià
溢价
approximately
yuē
约
31 percent
31%
31%
。
excluding / after deducting
kòuchú
扣除
the acquired party
bèi shōugòu fāng
被收购方
cash
xiànjīn
现金
assets
zīchǎn
资产
after
hòu
后
,
actual / net
shíjì
实际
net
jìng
净
acquisition value
shōugòu é
收购额
approximately
yuē
约
is
wéi
为
$5.7 billion
57 yì měiyuán
57亿美元
。
deal / transaction
jiāoyì
交易
structural particle
de
的
core / central
héxīn
核心
asset
zīchǎn
资产
is
shì
是
Terns
Terns
Terns
company
gōngsī
公司
developed / R&D
yánfā
研发
structural particle
de
的
drug candidate
hòuxuǎn yàowù
候选药物
TERN-701 (oral leukemia drug candidate)
TERN-701
TERN-701
。
TERN-701 (drug candidate)
TERN-701
TERN-701
is
shì
是
a type of
yī zhǒng
一种
oral / taken by mouth
kǒufú
口服
small molecule
xiǎo fēnzǐ
小分子
targeted / targeted therapy
bǎxiàng
靶向
drug / medication
yàowù
药物
,
currently in the stage of
zhèng chǔyú
正处于
treating / treatment of
zhìliáo
治疗
chronic myeloid leukemia
mànxìng lì xìbāo báixuèbìng
慢性粒细胞白血病
structural particle
de
的
clinical trial
línchuáng shìyàn
临床试验
stage / phase
jiēduàn
阶段
。
analysts
fēnxī rénshì
分析人士
to believe / to consider
rènwéi
认为
,
TERN-701 (drug candidate)
TERN-701
TERN-701
has the potential to / is expected to
yǒuwàng
有望
to become
chéngwéi
成为
value / market worth
shìzhí
市值
multi-billion dollars
shù shí yì měiyuán
数十亿美元
structural particle
de
的
blockbuster / major
zhòngpàng
重磅
product
chǎnpǐn
产品
,
and / also
bìng
并
against / toward
duì
对
Novartis (pharmaceutical company)
Nuòhuá
诺华
under / subsidiary brand
qí xià
旗下
structural particle
de
的
Scemblix (leukemia drug by Novartis)
Scemblix
Scemblix
to pose / to constitute
gòuchéng
构成
competition
jìngzhēng
竞争
。
this
cǐ cì
此次
acquisition
bìnggòu
并购
is
shì
是
Merck
Mòkè
默克
in the past year
jìn yī nián
近一年
within
nèi
内
completed
wánchéng
完成
structural particle
de
的
the third
dì sān bǐ
第三笔
major / significant
zhòngdà
重大
acquisition
shōugòu
收购
,
aimed at
zhǐzài
旨在
to strengthen
qiánghuà
强化
its
qí
其
cancer
áizhèng
癌症
R&D / research and development
yánfā
研发
pipeline (pharmaceutical)
guǎnxiàn
管线
。
its
qí
其
flagship / star
míngxīng
明星
drug
yàowù
药物
Keytruda (cancer immunotherapy drug)
Keytruda
Keytruda
structural particle
de
的
patent
zhuānlì
专利
will
jiāng
将
in
yú
于
the year 2028
2028 nián
2028年
expire / expiry
dàoqī
到期
。

New Words

zhìyào
制药
pharmaceutical
shōugòu
收购
to acquire
měi gǔ
每股
per share
yìjià
溢价
at a premium
hòuxuǎn yàowù
候选药物
drug candidate
kǒufú
口服
oral
bǎxiàng
靶向
targeted
línchuáng shìyàn
临床试验
clinical trial
guǎnxiàn
管线
pipeline
zhuānlì
专利
patent

News in English

Business

Merck to Acquire Terns Pharmaceuticals for $6.7 Billion

Merck announced a deal worth roughly $6.7 billion to acquire Terns Pharmaceuticals and its leukemia drug candidate TERN-701. The deal is aimed at strengthening Merck cancer pipeline ahead of the patent expiry of flagship drug Keytruda in 2028.

American pharmaceutical giant Merck announced on March 25 that it will acquire Terns Pharmaceuticals for approximately $6.7 billion.

This acquisition is being conducted at $53 per share, representing a premium of approximately 31 percent over recent share prices.

After deducting the acquired company's cash assets, the actual net acquisition value is approximately $5.7 billion.

The core asset of this transaction is Terns' drug candidate TERN-701.

TERN-701 is an oral small molecule targeted drug currently in clinical trial stages for treating chronic myeloid leukemia.

Analysts believe TERN-701 has the potential to become a multi-billion dollar blockbuster product and poses competition to Novartis' Scemblix leukemia drug.

This acquisition is Merck's third major acquisition completed within the past year, aimed at strengthening its cancer research and development pipeline.

Its flagship drug Keytruda's patent will expire in 2028.

More in Business

artificial intelligence
réngōng zhìnéng
人工智能
revenue / income
shōurù
收入
prospects / outlook
qiánjǐng
前景
to trigger / to cause
yǐnfā
引发
doubts / questions
yíwèn
疑问
,
semiconductor
bàndǎotǐ
半导体
stock price
gǔjià
股价
from
cóng
从
October
shí yuè
十月
peak / high point
gāodiǎn
高点
to retreat / to fall back
huíluò
回落
。

AI Revenue Uncertainty Pulls Semiconductor Stocks Off October Highs

United States
Měiguó
美国
stock market
gǔshì
股市
Friday
zhōuwǔ
周五
strongly / with force
qiángshì
强势
to rebound / to rally
fǎntán
反弹
,
Dow Jones Index
Dào Zhǐ
道指
gained more than
zhǎng chāo
涨超
400 points
400 diǎn
400点
,
to end / to conclude
jiéshù
结束
volatile / turbulent
dòngdàng
动荡
(particle)
de
的
one week
yī zhōu
一周
。

US Stocks Cap Volatile Week With Strong Friday Rally as Dow Gains Over 400 Points

international
guójì
国际
oil prices
yóujià
油价
to maintain / to sustain
wéichí
维持
high level / elevated level
gāowèi
高位
,
Nasdaq (stock exchange)
Nàsīdákè
纳斯达克
index
zhǐshù
指数
Thursday
zhōusì
周四
to close lower / to finish down
shōu diē
收跌
1.3 percent
bǎifēnzhī yī diǎn sān
1.3%
。

Nasdaq Slides 1.3 Percent as Brent Oil Holds Above 100 Dollars

OPEC
Ōu pèi kè
欧佩克
to announce
xuān bù
宣布
November
shí yī yuè
十一月
oil / petroleum
shí yóu
石油
output / production
chǎn liàng
产量
to maintain / to keep
bǎo chí
保持
unchanged
bù biàn
不变
。

OPEC Announces November Oil Output to Remain Unchanged